LABIED, S., WENDERS, F., GASPARD, O., RAVET, S., DESMECHT, A., Nisolle, M., & Henry, L. (21 August 2024). Birth of Thirty-Two Healthy Babies Following Transfer of Fresh and Frozen-Thawed Embryos Derived from Monopronuclear Zygotes: A Retrospective Study. Medicina, 60 (8), 1361. doi:10.3390/medicina60081361 Peer Reviewed verified by ORBi |
LABIED, S., WENDERS, F., DESMECHT, A., GASPARD, O., RAVET, S., Nisolle, M., & Henry, L. (22 June 2023). Birth of twenty-seven healthy babies following transfer of fresh and frozen-thawed embryos derived from monopronuclear zygotes: a retrospective study [Poster presentation]. ESHRE 39th Annual Meeting, Copenhague, Denmark. Peer reviewed |
LABIED, S., DESMECHT, A., WENDERS, F., GASPARD, O., RAVET, S., Nisolle, M., & Henry, L. (20 April 2023). BIRTH OF TWENTY-SEVEN HEALTHY BABIES FOLLOWING TRANSFER OF FRESH AND FROZEN- THAWED EMBRYOS DERIVED FROM MONOPRONUCLEAR ZYGOTES: A RETROSPECTIVE STUDY [Poster presentation]. 10eme IVIRMA CONGRESS, Malaga, Spain. Peer reviewed |
Squatrito, M., Blacher, S., Henry, L., LABIED, S., Noël, A., Nisolle, M., & Munaut, C. (19 October 2022). Comparison of Morphological and Digital-Assisted Analysis for BCL6 Endometrial Expression in Women with Endometriosis. Journal of Clinical Medicine, 11 (20), 6164. doi:10.3390/jcm11206164 Peer Reviewed verified by ORBi |
Henry, L., Vervier, J., BOUCHER, A., BRICHANT, G., GASPARD, O., LABIED, S., Munaut, C., RAVET, S., & Nisolle, M. (04 August 2022). Oocyte Cryopreservation in Patients with Endometriosis: Current Knowledge and Number Needed to Treat. Journal of Clinical Medicine, 11 (15), 4559. doi:10.3390/jcm11154559 Peer Reviewed verified by ORBi |
Henry, L., LABIED, S., Jouan, C., & Nisolle, M. (2021). Preservation of female fertility: The current therapeutic strategy. International Journal of Gynecology and Obstetrics. doi:10.1002/ijgo.13698 Peer Reviewed verified by ORBi |
Labied, S., Jouan, C., Wenders, F., Ravet, S., Gaspard, O., Thonon, F., Gridelet, V., Henry, L., PERRIER d'HAUTERIVE, S., & Nisolle, M. (2019). Comparison between paraffin and mineral oil covering on early human embryo culture: a prospective randomized study. Systems Biology in Reproductive Medicine, 1-6. doi:10.1080/19396368.2018.1492645 Peer Reviewed verified by ORBi |
Fransolet, M., NOEL, L., HENRY, L., LABIED, S., Blacher, S., NISOLLE, M., & Munaut, C. (2019). Evaluation of Z-VAD-FMK as an anti-apoptotic drug to prevent granulosa cell apoptosis and follicular death after human ovarian tissue transplantation. Journal of Assisted Reproduction and Genetics. doi:10.1007/s10815-018-1353-8 Peer Reviewed verified by ORBi |
Munaut, C., Fransolet, M., LABIED, S., & NISOLLE, M. (03 June 2016). Development and assessment of a new closed system for ovarian tissue vitrification [Paper presentation]. 12ième journées scientifiques du GRECOT, Paris, France. |
Fransolet, M., NOEL, L., HENRY, L., LABIED, S., Noël, A., Nisolle, M., & Munaut, C. (25 January 2016). − Evaluation of Z-VAD-FMK as an anti-apoptotic drug to prevent granulosa cells apoptosis and follicle death after ovarian tissue transplantation [Poster presentation]. GIGA day. |
HENRY, L., Fransolet, M., LABIED, S., Blacher, S., MASEREEL, M.-C., Foidart, J.-M., Noël, A., Nisolle, M., & Munaut, C. (2016). Supplementation of transport and freezing media with anti-apoptotic drugs improves ovarian cortex survival. Journal of Ovarian Research. doi:10.1186/s13048-016-0216-0 Peer Reviewed verified by ORBi |
Fransolet, M., HENRY, L., LABIED, S., Noël, A., Foidart, J.-M., NISOLLE, M., & Munaut, C. (14 June 2015). In vitro evaluation of an anti-apoptotic drug, Z-VAD-FMK, for further use in ovarian tissue transplantation [Poster presentation]. The 31th Annual Meeting of the European Society of Human Reproduction and Embryology (ESHRE), Lisbonne, Portugal. |
Fransolet, M., HENRY, L., LABIED, S., Noël, A., Foidart, J.-M., Nisolle, M., & Munaut, C. (13 May 2015). In vitro evaluation of Z-VAD-FMK, an anti-apoptotic drug, for further use in ovarian tissue transplantation [Poster presentation]. GIGA-Cancer day. |
Fransolet, M., HENRY, L., LABIED, S., Noël, A., Foidart, J.-M., Nisolle, M., & Munaut, C. (11 February 2015). In vitro evaluation of Z-VAD-FMK, an anti-apoptotic drug, for further use in ovarian tissue transplantation [Poster presentation]. Séminaire des jeunes chercheurs Télévie. |
Fransolet, M., HENRY, L., LABIED, S., Noël, A., Foidart, J.-M., Nisolle, M., & Munaut, C. (31 January 2015). Follicular maintenance after oavrian tissue transplantation with the anti-apoptotic drug Z-VAD-FMK [Poster presentation]. Meeting annuel de la Belgian Association for Cancer Research (BACR). |
HENRY, L., Fransolet, M., LABIED, S., Masereel, M.-C., Blacher, S., Donneau, A.-F., Kirschvink, N., Noël, A., Foidart, J.-M., Nisolle, M., & Munaut, C. (27 January 2015). Limitation of damage to ovarian cortex during cryopreservation by addition of anti-apoptotic drugs in transport and freezing media [Poster presentation]. GIGA day. |
Fransolet, M., HENRY, L., LABIED, S., Noël, A., Foidart, J.-M., Nisolle, M., & Munaut, C. (27 January 2015). In vitro evaluation of Z-VAD-FMK, an anti-apoptotic drug, for further use in ovarian tissue transplantation [Poster presentation]. GIGA day. |
Fransolet, M., HENRY, L., LABIED, S., Noël, A., Foidart, J.-M., Nisolle, M., & Munaut. (16 January 2015). In vitro evaluation of Z-VAD-FMK, an anti-apoptotic drug, for further use in ovarian tissue transplantation [Poster presentation]. International Society of Fertility Preservation (ISFP) meeting: “Freezing of oocytes, embryos and ovarian tissue: focus on fertility management and fertility preservation”. |
Henry, L., LABIED, S., Fransolet, M., Kirschvink, N., Blacher, S., Noël, A., Foidart, J.-M., Nisolle, M., & Munaut, C. (2015). Isoform 165 of vascular endothelial growth factor in collagen matrix improves ovine cryopreserved ovarian tissue revascularisation after xenotransplantation in mice. Reproductive Biology and Endocrinology, 13 (1), 15. doi:10.1186/s12958-015-0015-2 Peer Reviewed verified by ORBi |
Munaut, C., Leenders, J., LABIED, S., Martin, M., Govaerts, B., De Tullio, P., & NISOLLE, M. (2015). Use of an endometriosis model in rats to reveal new non invasive biomarkers [Paper presentation]. 31ème meeting annuel de l’European Society of Human Reproduction & Embryology (ESHRE). |
Fransolet, M., HENRY, L., LABIED, S., Noël, A., Nisolle, M., & Munaut, C. (2015). In vitro evaluation of the anti-apoptotic drug Z-VAD-FMK on human ovarian granulosa cell lines for further use in ovarian tissue transplantation. Journal of Assisted Reproduction and Genetics. doi:10.1007/s10815-015-0536-9 Peer Reviewed verified by ORBi |
GASPARD, O., Danthine, D., RAVET, S., WENDERS, F., JOUAN, C., THONON, F., LABIED, S., GRIDELET, V., Dubois, M., PERRIER d'HAUTERIVE, S., & NISOLLE, M. (2015). Neonatal outcomes after IMSI and ICSI at the CPMA of the University of Liège [Poster presentation]. Congrès 2015 de la European Society for Human Reproduction and Embryology. |
Fransolet, M., Henry, L., LABIED, S., Masereel, M.-C., Blacher, S., Noël, A., Foidart, J.-M., Nisolle, M., & Munaut, C. (2015). Influence of mouse strain on ovarian tissue recovery after engraftment with angiogenic factor. Journal of Ovarian Research, 8 (1), 14. doi:10.1186/s13048-015-0142-6 Peer Reviewed verified by ORBi |
HENRY, L., Fransolet, M., LABIED, S., MASEREEL, M.-C., Blacher, S., Donneau, A.-F., Kirschvink, N., Noël, A., Foidart, J.-M., Nisolle, M., & Munaut, C. (14 November 2014). Use of anti-apoptotic drugs in transport and freezing media of cryopreserved sheep ovarian cortex to improve tissue survival [Poster presentation]. 32ème meeting scientifique de la Belgian Society of Reproductive Medicine (BSRM). |
Fransolet, M., HENRY, L., LABIED, S., Noël, A., Foidart, J.-M., Nisolle, M., & Munaut, C. (14 November 2014). Potential effect of the anti-apoptotic drug Z-VAD-FMK on follicular maintenance in ovarian tissue cryopreservation [Poster presentation]. 32ème meeting scientifique de la Belgian Society of Reproductive Medicine (BSRM). |
Fransolet, M., HENRY, L., LABIED, S., Noël, A., Foidart, J.-M., Nisolle, M., & Munaut, C. (30 September 2014). Does Z-VAD-FMK treatment could decrease follicular loss after autografting of cryopreserved ovarian tissue? [Poster presentation]. Mini-symposium annuel de l’EDT-Cancérologie Expérimentale. |
Fransolet, M., HENRY, L., Blacher, S., Colige, A., Kirschvink, N., Foidart, J.-M., Noël, A., LABIED, S., Nisolle, M., & Munaut, C. (19 May 2014). Ovarian tissue recovery in SCID and NOD-SCID mice after VEGF111 or VEGF165 graft treatment [Poster presentation]. GIGA-Cancer day. |
Fransolet, M., HENRY, L., Blacher, S., Colige, A., Kirschvink, N., Foidart, J.-M., Noël, A., LABIED, S., Nisolle, M., & Munaut, C. (15 May 2014). Impact of mice strains in ovarian tissue recovery after VEGF111 or VEGF165 graft treatment [Poster presentation]. BioLiège Bioforum 2014. |
Fransolet, M., HENRY, L., Blacher, S., Colige, A., Kirschvink, N., Foidart, J.-M., Noël, A., LABIED, S., Nisolle, M., & Munaut, C. (01 February 2014). Impact of mice strains in ovarian tissue recovery after VEGF111 or VEGF165 graft treatment [Poster presentation]. Belgian Association for Cancer Research (BACR) annual meeting 2014. |
Fransolet, M., HENRY, L., Blacher, S., Colige, A., Kirschvink, N., Foidart, J.-M., Noël, A., LABIED, S., Nisolle, M., & Munaut, C. (27 January 2014). Impact of mice strains in ovarian tissue recovery after VEGF111 or VEGF165 graft treatment [Poster presentation]. GIGA day. |
GASPARD, O., RAVET, S., WENDERS, F., JOUAN, C., THONON, F., LABIED, S., GRIDELET, V., Hincourt, N., Lorquet, S., DECHENNE, V., GINER LLORET, C., Dubois, M., PERRIER d'HAUTERIVE, S., & NISOLLE, M. (2014). Five years of IMSI at CPMA-University of Liège [Poster presentation]. 32ème congrès de la Belgian Society of Reproductive Medicine. |
Fransolet, M., Labied, S., Henry, L., Masereel, M.-C., Rozet, E., Kirschvink, N., Nisolle, M., & Munaut, C. (2014). Strategies for Using the Sheep Ovarian Cortex as a Model in Reproductive Medicine. PLoS ONE, 9 (3), 91073. doi:10.1371/journal.pone.0091073 Peer Reviewed verified by ORBi |
Henry, L., Labied, S., Chiaradia, F., Munaut, C., & NISOLLE, M. (2014). Cancer et droit à la maternité. Revue Médicale de Liège, 69 (4), 188-193. Peer reviewed |
Fransolet, M., HENRY, L., Foidart, J.-M., Noël, A., LABIED, S., Nisolle, M., & Munaut, C. (05 December 2013). Z-VAD-FMK treatment prevents granulosa cells apoptosis induced by etoposide but not by hypoxia and serum starvation in vitro [Poster presentation]. Séminaire des chercheurs Télévie 2014. |
Fransolet, M., HENRY, L., Foidart, J.-M., Noël, A., LABIED, S., Nisolle, M., & Munaut, C. (07 November 2013). Z-VAD-FMK treatment prevents granulosa cells apoptosis induced by etoposide but not by hypoxia and serum starvation in vitro [Poster presentation]. 3rd World Congress of the International Society for Fertility Preservation (ISFP). |
HENRY, L., Fransolet, M., LABIED, S., Munaut, C., Kirschvink, N., Noël, A., Nisolle, M., & Foidart, J.-M. (17 May 2013). Effect of anti-apoptotic drugs to prevent follicles loss during ovarian cortex transport and cryopreservation [Poster presentation]. GIGA-Cancer day. |
Fransolet, M., HENRY, L., Foidart, J.-M., Noël, A., LABIED, S., Nisolle, M., & Munaut, C. (17 May 2013). Do anti-apoptotic drugs prevent follicle loss after ovarian cortical graft to patient in remission? [Poster presentation]. GIGA-Cancer day. |
HENRY, L., Fransolet, M., LABIED, S., Munaut, C., Kirschvink, N., Noël, A., Nisolle, M., & Foidart, J.-M. (21 March 2013). Do anti-apoptotic drugs prevent follicles loss during ovarian cortex transport and cryopreservation? [Poster presentation]. The International Congress on Oncological Perspectives of Fertility Preservation: Gynecological & Breast Cancer. |
Fransolet, M., HENRY, L., Rozet, E., Blacher, S., Masereel, M.-C., Kirschvink, N., Foidart, J.-M., Noël, A., Nisolle, M., LABIED, S., & Munaut, C. (02 February 2013). How to use sheep ovarian tissue as a model to restore fertility in young women who received gonadotoxic treatment? [Poster presentation]. Belgian Association for Cancer Research (BACR) annual meeting. |
Labied, S., Delforge, Y., Munaut, C., Blacher, S., Colige, A., Delcombel, R., HENRY, L., Fransolet, M., JOUAN, C., Perrier d'Hauterive, S., Noël, A., Nisolle, M.* , & Foidart, J.-M.*. (2013). Isoform 111 of vascular endothelial growth factor (VEGF111) improves angiogenesis of ovarian tissue xenotransplantation. Transplantation, 95 (3), 426-433. doi:10.1097/TP.0b013e318279965c Peer Reviewed verified by ORBi * These authors have contributed equally to this work. |
HENRY, L., Delforge, Y., Blacher, S., Colige, A., Delcombel, R., Fransolet, M., JOUAN, C., PERRIER d'HAUTERIVE, S., Noël, A., Nisolle, M., Foidart, J.-M., Munaut, C., & LABIED, S. (10 December 2012). Isoform 111 of vascular endothelial growth factor (VEGF111) improves angiogenesis of ovarian tissue xenotransplantation [Poster presentation]. Televie's Researchers Seminar. |
Fransolet, M., HENRY, L., Rozet, E., Blacher, S., Masereel, M.-C., Kirschvink, N., Noël, A., Foidart, J.-M., NISOLLE, M., Labied, S., & Munaut, C. (10 December 2012). Use of Sheep Ovarian Tissue as a Model to Restore Fertility in Young Cancerous Women [Poster presentation]. Séminaire des chercheurs Télévie 2013. |
HENRY, L., Fransolet, M., LABIED, S., Blacher, S., Munaut, C., Colige, A., Kirschvink, N., Noël, A., Nisolle, M., & Foidart, J.-M. (30 November 2012). Does vascular endothelial growth factor improve ovarian tissue recovery after cryopreservation? [Poster presentation]. Belgian Society of Reproductive Medicine. |
Fransolet, M., HENRY, L., Rozet, E., Blacher, S., Masereel, M.-C., Kirschvink, N., Foidart, J.-M., Noël, A., Nisolle, M., Munaut, C., & LABIED, S. (30 November 2012). Assessment of follicular density in sheep ovarian tissue and impact on experimental results [Poster presentation]. Belgian Society of Reproductive Medicine. |
Fransolet, M., HENRY, L., Blacher, S., Colige, A., Kirschvink, N., PERRIER d'HAUTERIVE, S., Foidart, J.-M., Noël, A., LABIED, S., Nisolle, M., & Munaut, C. (22 June 2012). Influence of VEGF111 treatment on ovarian tissue xenografts in different mice strains [Poster presentation]. GIGA-Cancer day. |
Fransolet, M., HENRY, L., Blacher, S., Colige, A., Kirschvink, N., PERRIER d'HAUTERIVE, S., Foidart, J.-M., Noël, A., Nisolle, M., Munaut, C., & LABIED, S. (04 May 2012). Comparison of different mice strains to test ovarian VEGF111 treated graft recovery [Poster presentation]. GIGA day. |
Fransolet, M., HENRY, L., Blacher, S., Colige, A., Kirschvink, N., PERRIER d'HAUTERIVE, S., Foidart, J.-M., Noël, A., Munaut, C., LABIED, S., & Nisolle, M. (18 April 2012). Impact of mice strains in ovarian tissue recovery after VEGF111 graft treatment [Poster presentation]. Biomedica, The European Life Sciences Summit. |
Henry, L., Fransolet, M., Labied, S., Blacher, S., Munaut, C., Colige, A., Kirschvink, N., Noël, A., Nisolle, M., & Foidart, J.-M. (2012). Does vascular endothelial growth factor improve ovarian tissue recovery after cryopreservation? In Giornale italiano di obstetricia e gynecologia (pp. 34(1):203). Peer reviewed |
Labied, S., Delforge, Y., Blacher, S., Munaut, C., Signolle, N., Colige, A., Janssen, L., HENRY, L., Perrier d'Hauterive, S., JOUAN, C., Kirschvink, N., Noël, A., Nisolle, M., & Foidart, J.-M. (2012). Isoform 111 of vascular endothelial growth factor (VEGF111) improves angiogenesis of ovarian tissue xenotransplantation. Journal of Assisted Reproduction and Genetics, 28 (11), 1009. Peer Reviewed verified by ORBi |
Labied, S., Blacher, S., Carmeliet, P., Noël, A., Frankenne, F., Foidart, J.-M., & Munaut, C. (2011). Transient reduction of placental angiogenesis in PAI-1 deficient mice. Physiological Genomics, 43 (4), 188-98. doi:10.1152/physiolgenomics.00147.2010 Peer Reviewed verified by ORBi |
LABIED, S., Blacher, S., Carmeliet, P., Noël, A., Frankenne, F., Foidart, J.-M., & Munaut, C. (2011). Transient reduction of placental angiogenesis in PAI-1 deficient mice [Poster presentation]. Giga Day, Liège, Belgium. |
LABIED, S., Delforge, Y., Blacher, S., Munaut, C., Signole, N., Colige, A., Janssen, L., HENRY, L., Fransolet, M., PERRIER d'HAUTERIVE, S., JOUAN, C., Kirschvink, N., Noël, A., NISOLLE, M., & Foidart, J.-M. (2011). Isoform 111 of vascular endothelial growth factor (VEGF111) improves angiogenesis of ovarian tissue xenotransplantation. Journal of Assisted Reproduction and Genetics, 28, 1099. |
HENRY, L., Fransolet, M., LABIED, S., Blacher, S., Munaut, C., Kirschvinck, N., Noël, A., NISOLLE, M., & Foidart, J.-M. (2011). Does isoforms 111 and 165 of vascular endothelial growth factor (VEGF111 and 165) improve transplanted ovarian tissue survival? Journal of Assisted Reproduction and Genetics, 28, 1009-1010. |
Henry, L., Fransolet, M., LABIED, S., Blacher, S., Munaut, C., Colige, A., Kirschvink, N., Noël, A., NISOLLE, M., & Foidart, J.-M. (2011). Does isoforms 111 and 165 of vascular endothelial growth factor (VEGF111 and 165) improve transplanted ovarian tissue survival? Journal of Assisted Reproduction and Genetics, 28, 1009-10. Peer Reviewed verified by ORBi |
LABIED, S., Blacher, S., Delforge, Y., Munaut, C., NISOLLE, M., & Foidart, J.-M. (27 May 2010). Vascular endothelial growth factor (VEGF) improves vessel density of transplanted sheep ovarian cortex [Poster presentation]. 1st International Congress on Controversies of Stem Cells, Reproductive Cells, Tissue and Organs (CRYO), Valence, Spain. |
Labied, S., Galant, C., Nisolle, M., Ravet, S., Munaut, C., Marbaix, E., Foidart, J.-M., & Frankenne, F. (2009). Differential elevation of matrix metalloproteinase expression in women exposed to levonorgestrel-releasing intrauterine system for a short or prolonged period of time. Human Reproduction, 24 (1), 113-121. doi:10.1093/humrep/den339 Peer Reviewed verified by ORBi |
Alvarez Gonzalez, M.-L., Galant, C., Frankenne, F., Nisolle, M., Labied, S., Foidart, J.-M., Marbaix, E., & Beliard, A. (2009). Development of an animal experimental model to study the effects of levonorgestrel on the human endometrium. Human Reproduction, 24 (3), 697-704. doi:10.1093/humrep/den437 Peer Reviewed verified by ORBi |
Labied, S. (2008). Rôle des protéases et de leurs inhibiteurs dans la placentation et la vascularisation endométriale [Doctoral thesis, Université de Liège]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/315252 |
Ravet, S., Munaut, C., Blacher, S., Brichant, G., Labied, S., Beliard, A., Chabbert-Buffet, N., Bouchard, P., Foidart, J.-M., & Pintiaux, A. (2008). Persistence of an intact endometrial matrix and vessels structure in women exposed to VA-2914, a selective progesterone receptor modulator. Journal of Clinical Endocrinology and Metabolism, 93 (11), 4525-31. doi:10.1210/jc.2008-0731 Peer Reviewed verified by ORBi |
Ravet, S., Labied, S., Blacher, S., Frankenne, F., Munaut, C., Fridman, V., Beliard, A., Foidart, J.-M., & Nisolle, M. (December 2007). Endometrial vessel maturation in women exposed to levonorgestrel-releasing intrauterine system for a short or prolonged period of time. Human Reproduction, 22 (12), 3084-3091. doi:10.1093/humrep/dem238 Peer Reviewed verified by ORBi |
Oltenfreiter, R., Staelens, L., Labied, S., Kersemans, V., Frankenne, F., Noël, A., Van de Wiele, C., & Slegers, G. (2005). Tryptophane-based biphenylsulfonamide matrix metalloproteinase inhibitors as tumor imaging agents. Cancer Biotherapy and Radiopharmaceuticals, 20 (6), 639-47. doi:10.1089/cbr.2005.20.639 Peer Reviewed verified by ORBi |
Le Maire, S., Blacher, S., Labied, S., Frankenne, F., Foidart, J.-M., & Verly, J. (2005). Image analysis quantification of the angiogenesis on an embryonic implantation site [Paper presentation]. 9th European Congress for Stereology and Image Analysis and 7th International Conference on Stereology and Image Analysis in Materials Science STERMAT. |
Le Maire, S., Blacher, S., Labied, S., Frankenne, F., Foidart, J.-M., & Verly, J. (2005). Caractérisation par analyse d’images de l’angiogenèse sur des coupes histologiques [Paper presentation]. 20ème Colloque sur le Traitement du Signal et des Images (GRETSI’O5), Louvain-La-Neuve, Belgium. |